Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma

Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma

Nora Drick,1,* Katrin Milger,2,* Benjamin Seeliger,1 Jan Fuge,1 Stephanie Korn,3 Roland Buhl,3 Maren Schuhmann,4 Felix Herth,4 Benjamin Kendziora,5 Juergen Behr,2 Nikolaus Kneidinger,2 Karl-Christian Bergmann,5 Christian Taube,6 Tobias Welte,1 Hendrik Suhling1 1Department of Respiratory Medicine, Ha...

Full description

Bibliographic Details
Main Authors: Drick N, Milger K, Seeliger B, Fuge J, Korn S, Buhl R, Schuhmann M, Herth F, Kendziora B, Behr J, Kneidinger N, Bergmann KC, Taube C, Welte T, Suhling H
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:Journal of Asthma and Allergy
Subjects:
benralizumab
eosinophils
mepolizumab
reslizumab
severe asthma
Online Access:https://www.dovepress.com/switch-from-il-5-to-il-5-receptor-alpha-antibody-treatment-in-severe-e-peer-reviewed-article-JAA

Internet

https://www.dovepress.com/switch-from-il-5-to-il-5-receptor-alpha-antibody-treatment-in-severe-e-peer-reviewed-article-JAA

Similar Items